From: Construction of polycistronic baculovirus surface display vectors to express the PCV2 Cap(d41) protein and analysis of its immunogenicity in mice and swine
Group
CD4+ (%)
CD8+ (%)
CD4+/CD8+ ratio
CE
24.2 ± 0.49
5.9 ± 0.93*
4.14 ± 0.57
4Cap(d41)
39.5 ± 0.7*
1.5 ± 0.04
27.1 ± 1.16*
Commercial vaccine
21.9 ± 0.85
1.2 ± 0.04
18.74 ± 1.4*